The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee. (Q51002697)
Jump to navigation
Jump to search
scientific article published in January 1996
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee. |
scientific article published in January 1996 |
Statements
The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee. (English)
1 reference
W Makarowski
1 reference
A Weaver
1 reference
B Rubin
1 reference
J Caldwell
1 reference
F G McMahon
1 reference
R J Noveck
1 reference
D Lee
1 reference
H Offenberg
1 reference
M Sack
1 reference
D Sikes
1 reference
R Trapp
1 reference
S Rush
1 reference
M Kuss
1 reference
J Ganju
1 reference
T S Bocanegra
1 reference
J M Ratliff
1 reference
1 January 1996
1 reference
18
1 reference
1
1 reference
114-124
1 reference